These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention. Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831 [TBL] [Abstract][Full Text] [Related]
13. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients]. Tachibana E; Watanabe I; Nagao K; Kanmatsuse K J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study]. Szucs TD; Bertel O; Darioli R; Gutzwiller F; Mordasini R Praxis (Bern 1994); 2000 Apr; 89(18):745-52. PubMed ID: 10823012 [TBL] [Abstract][Full Text] [Related]
15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
16. [Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids]. Arnheim K MMW Fortschr Med; 2000 Jun; 142(24):18. PubMed ID: 10895577 [No Abstract] [Full Text] [Related]
17. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention]. Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895 [No Abstract] [Full Text] [Related]
18. [Diagnosis and treatment of hyperlipoidaemias]. Wolfram G Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214 [No Abstract] [Full Text] [Related]
19. The detection and management of dyslipidaemia in children and adolescents. Ose L; Tonstad S Acta Paediatr; 1995 Nov; 84(11):1213-5. PubMed ID: 8580613 [TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial. Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H; Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]